COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" (External organisation)

    Activity: Membership types › Membership of network

    Description

    COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" Representative of Latvia in the Steering Committee
    Period19 Oct 2017 → 18 Apr 2022
    Held atCOST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies", Belgium
    Degree of RecognitionInternational